Take 2-3 minutes to tell us what you are looking for today.
Your feedback will help us improve our site.
No thanks
Hepatitis C virus is a blood borne virus and one of several viruses that cause Hepatitis (inflammation of the liver). More than 110,000 people in Ontario are infected with the hepatitis C virus. Symptoms often do not appear for many years, and about 35,000 Ontarians do not realize they are infected. Research has shown that an average of 25% of individuals infected with Hepatitis C will clear the virus within 6 months of becoming infected. Those who do not clear the virus are at risk of developing cirrhosis (scarring of the liver) and liver cancer. This slow and silent virus can take 20-30 years to cause liver damage.
Most people who become infected do not have symptoms. Six to seven weeks after exposure, some will develop fatigue, nausea, loss of appetite, jaundice (yellow skin and eyes) and dark urine. It is not unusual to experience ongoing fatigue. Symptoms may also develop very late in the course of the disease when liver damage has occurred.
Hepatitis C is spread through direct contact with the blood of an infected person. Ten percent have no known risk factors. Sources of infection can include the following:
Less common ways in which hepatitis C can be transmitted:
If you had a blood transfusion or were treated with a blood product before 1992, you may have been infected by the hepatitis C virus. If so, you may be eligible for assistance. For more information, visit http://www.hepcontario.ca/en/blood.html for more detailed information.
Those individuals who do not clear the Hepatitis C virus (chronic form) are infectious for their lifetime.
The main test for Hepatitis C is an anti-HCV test. It detects the Hepatitis C virus (HCV) antibodies in the blood. These antibodies are produced in response to infection by the Hepatitis C virus. To determine if the virus has been cleared, another type of blood test called PCR RNA qualitative test can be ordered.
Some people may clear the virus with antiviral therapy. Those with persistently high liver ALT enzymes (sign of liver inflammation) should be referred to a specialist for possible treatment. A combination therapy of Interferon (by injection) and Ribavirin (in pill form), has a higher response rate than Interferon treatment alone. Length of treatment can vary from 6-12 months. The Trillium Drug Plan (application at local pharmacy) is available to defer cost. Liver transplant may be the treatment of choice if Hepatitis C is life threatening.
For further education, counselling and support, there are two organizations you can access to help manage your daily life effectively:
For more information, contact the Public Health Department, Infectious Diseases Program, 905-688-8248 ext. 7330 or 1-888-505-6074 or visit Ontario's Hepatitis C site.
This information is intended to provide general health-related information about Hepatitis C. It is not intended to replace medical consultation by your physician and/or other health care professionals.